Sphera Funds Management Ltd. Abb Vie Inc. Transaction History

Sphera Funds Management Ltd.

$545 Million
Q3 2024

A detailed history of Sphera Funds Management Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 38,000 shares of ABBV stock, worth $6.72 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

38,000

Previous 38,000 -0.0%

Holding current value

$6.72 Million

Previous $6.52 Million 15.15%

% of portfolio

1.38%

Previous 0.95%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.28 Million - $1.46 Million	-8,000 Reduced 17.39%	38,000 $6.92 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1.34 Million - $1.55 Million	-10,000 Reduced 17.86%	46,000 $6.86 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $927,569 - $1.15 Million	-7,000 Reduced 11.11%	56,000 $7.54 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $433,830 - $499,620	3,000 Added 5.0%	63,000 $10 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $14.1 Million - $17 Million	-102,285 Reduced 63.03%	60,000 $9.7 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $7.53 Million - $8.64 Million	-56,100 Reduced 25.69%	162,285 $21.8 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $3.77 Million - $4.79 Million	27,391 Added 14.34%	218,385 $33.4 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $36.1 Million - $44.7 Million	-273,200 Reduced 58.85%	190,994 $31 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $14.2 Million - $18 Million	-132,100 Reduced 22.15%	464,194 $62.9 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $24.5 Million - $27.8 Million	230,100 Added 62.84%	596,294 $64.3 Million
Q2 2021 Aug 17, 2021	SELL	$105.21 - $117.21 $24.5 Million - $27.3 Million	-233,306 Reduced 38.92%	366,194 $41.2 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $26.5 Million - $29.2 Million	259,500 Added 76.32%	599,500 $64.9 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $36.2 Million - $48.9 Million	-450,000 Reduced 56.96%	340,000 $36.4 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $4.76 Million - $5.59 Million	55,402 Added 7.54%	790,000 $69.2 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $41.8 Million - $55.9 Million	569,598 Added 345.21%	734,598 $72.1 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $10.6 Million - $16.1 Million	165,000 New	165,000 $12.6 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Abb Vie Inc. Transaction History